Cationic Lipids with Acetal Linkages for siRNA Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional cationic lipids used for siRNA delivery, such as DLinDMA, have extended tissue half-lives and cause hepatocellular toxicity due to prolonged liver residence, necessitating a cationic lipid scaffold that is hydrolytically unstable and has reduced liver residence times.
Innovation Solution
The development of novel cationic lipids incorporating acetals and ketals, which are low pH-sensitive, providing a chemical handle for degradation and reducing toxicity and residence time in the liver.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional cationic lipids such as DLinDMA are used for siRNA delivery, then efficient gene delivery and cellular uptake are achieved, but extended tissue half-life and hepatocellular toxicity occur due to prolonged liver residence
Solution Approach 1:
The patent modifies the chemical structure of cationic lipids by incorporating hydrolytically unstable bonds (acetals, ketals, orthoesters, carbamates) that change the stability parameter of the lipid scaffold. This allows the lipid to degrade at a controlled rate, reducing liver residence time and associated toxicity while maintaining sufficient stability for gene delivery function.
Solution Approach 2:
The invention creates composite lipid structures combining stable hydrophobic tails with unstable hydrophilic heads containing degradable bonds. This composite approach allows different parts of the molecule to have different stability characteristics - the hydrophobic portion maintains structural integrity for membrane interaction while the hydrophilic portion degrades to reduce toxicity.
2Productivity
If traditional cationic lipids are used to form lipid nanoparticles, then effective oligonucleotide delivery is achieved, but prolonged liver residence time extends tissue half-life
Solution Approach 1:
The patent changes the temporal parameter of lipid stability by introducing hydrolytically unstable bonds that control the degradation kinetics. This allows optimization of the residence time parameter - long enough to achieve delivery function but short enough to prevent prolonged tissue accumulation and toxicity.
3Stability of the object's composition
If cationic lipids with high stability are used, then sustained delivery function is maintained, but hepatocellular toxicity increases due to reduced degradation
Solution Approach 1:
The patent segments the lipid molecule into functionally distinct regions: a stable hydrophobic tail region that maintains structural integrity for membrane interaction and a unstable hydrophilic head region containing degradable bonds that controls toxicity. This segmentation allows different stability requirements to be met in different parts of the same molecule.
Solution Approach 2:
The hydrolytically unstable bonds (acetals, ketals, orthoesters, carbamates) act as intermediary elements that mediate between the stable hydrophobic portion and the aqueous environment. These intermediaries provide controlled degradation pathways that reduce toxicity while maintaining sufficient stability for the lipid's delivery function.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel cationic lipids facilitate efficient delivery of siRNA and miRNA by forming lipid nanoparticles, achieving targeted gene knockdown with reduced liver toxicity and improved stability, as demonstrated in mouse, rat, and non-human primate models.
Implementation Method 1
The present invention employs acetals and ketals to provide a low pH sensitive chemical handle for degradation
Data Source
AI summary
The instant invention provides for novel cationic lipids that can be used in combination with other lipid components such as cholesterol and PEG-lipids to form lipid nanoparticles with oligonucleotides. It is an object of the instant invention to provide a cationic lipid scaffold that is susceptible to hydrolytic instability that may translate into reduced liver residence times and reduced hepatocellular toxicity. The present invention employs acetals and ketals to provide a low pH sensitive chemical handle for degradation.